Gene Signal
engages in discovery, development, and commercialization of oligonucleotides, proteins and monoclonal antibodies... Read moreGene Signal
engages in discovery, development, and commercialization of oligonucleotides, proteins and monoclonal antibodies... Read more
News
Oct 31, 2017
Business Wire
Press Release: Gene Signal : Corneal Neovascularization - Global Clinical Trials Review, H2, 2017 - Research and Markets
Apr 18, 2016
Business Wire
Press Release: Gene Signal : Global Corneal Graft Rejection Pipeline Review, H1 2016 - Research and Markets
Sep 11, 2015
BUSINESS WIRE
Press Release: Gene Signal : Research and Markets: Corneal Neovascularization - Global Clinical Trials Review, H2, 2015
Jun 24, 2015
BUSINESS WIRE
Press Release: Gene Signal : Research and Markets: Corneal Neovascularization Therapeutics Pipeline Review 2015 - 4 Companies & 10 Drug Profiles
Jan 02, 2015
BUSINESS WIRE
Press Release: Gene Signal : Research and Markets: Corneal Neovascularization - Pipeline Review, H2 2014
Nov 11, 2014
BUSINESS WIRE
Press Release: Gene Signal : Research and Markets: Global Retinopathy Of Prematurity Therapeutics Pipeline Review, H2 2014 - Analysis of 6 Companies & 8 Drug Profiles
May 15, 2014
BIOSPACE
Gene Signal: Gene Signal Announces Positive Data From Phase 3 Trial of Aganirsen Eye Drops For Corneal Neovascularisation Due To Inflammation, A Rare Eye Disease With European Orphan Drug Designation
May 12, 2014
BIOCENTURY
genesignal: Gene Signal publishes mixed data for aganirsen
Gene Signal Competitors
1
2
3
4
5
6
7
8
9
10